Compared with those in healthy livers, theCYP2E1,CAT,ADH, andALDHtranscription levels are upregulated in the livers of patients with MASLD,90and these levels in patients with severe MASLD resemble those in patients with alcohol-associated hepatitis. This evidence concerns the gene AVP and metabolic dysfunction-associated steatotic liver disease.